ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Tobaccos Council Awards New Grants

April 3, 1981

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

In Brief: Kessler Urges Cardiologists To Fight Teen Smoking; ODAC To Meet Dec. 14

December 1, 1995

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992